Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: Long-term results of a small clinical trial

Vascular and Endovascular Surgery

Volumn 43, Issue 5, 2009, Pages 452-456

  HØgh, Annette ^a   Vammen, Steen ^b   Ostergaard, Lars ^b   Joensen, Jette B ^c   Henneberg, Esklid W ^a   Lindholt, Jes S ^a  

^a VIBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Abdominal aortic aneurysm; Long term follow up; Macrolide; Prophylactic medicine

Indexed keywords

PLACEBO; ROXITHROMYCIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION; VASCULAR SURGERY;

AGED; ANTI-BACTERIAL AGENTS; AORTIC ANEURYSM, ABDOMINAL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ROXITHROMYCIN;

EID: 70350516477     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574409335037     Document Type: Article

References (30)

1. Ernst CB Abdominal aortic aneurysm. N Engl J Med. 1993 ; 328 (17). 1167-1172.
2. Lindholt JS, Fasting H., Henneberg EW, Ostergaard L. A review of Chlamydia pneumonia and atherosclerosis. Eur J Vasc Endovasc Surg. 1999 ; 17: 283-289.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340 (2). 115-126.
4. Libby P., Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105 (9). 1135-1143.
5. Lindholt JS, Ashton HA, Scott RA Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg. 2001 ; 34 (2). 212-215.
6. Halme S., Juvonen T., Laurila A., et al. Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms. Eur J Clin Invest. 1999 ; 29 (6). 546-552.
7. LaBiche R., Koziol D., Quinn TC, et al. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke. 2001 ; 32 (4). 855-860. (Pubitemid 32285148)
8. Kaperonis EA, Liapis CD, Kakisis JD, Perrea D., Kostakis AG, Karayannakos PE The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology. J Vasc Surg. 2006 ; 44 (6). 1198-1204.
9. Kaperonis EA, Liapis CD, Kakisis JD, et al. Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2006 ; 31 (5). 509-515.
10. Cannon CP, Braunwald E., McCabe CH, et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med. 2005 ; 352 (16). 1646-1654.
11. Grayston JT Antibiotic treatment of atherosclerotic cardiovascular disease. Circulation. 2003 ; 107 (9). 1228-1230.
12. Elkind MS, Lin IF, Grayston JT, Sacco RL Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke. 2000 ; 31 (7). 1521-1525.
13. Lindholt JS, Juul S., Vammen S., Lind I., Fasting H., Henneberg EW. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. Br J Surg. 1999 ; 86 (5). 634-638.
14. Pyo R., Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000 ; 105 (11). 1641-1649.
15. Curci JA, Petrinec D., Liao S., Golub LM, Thompson RW Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg. 1998 ; 28 (6). 1082-1093.
16. Kol A., Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation. 1998 ; 98 (4). 300-307.
17. Thompson RW, Baxter BT MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci. 1999 ; 878: 159-178.
18. Boyle JR, McDermott E., Crowther M., Wills AD, Bell PR, Thompson MM Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg. 1998 ; 27 (2). 354-361. (Pubitemid 28136817)
19. Lindholt JS, Juul S., Fasting H., Henneberg EW Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ. 2005 ; 330 (7494). 750.
20. Sterpetti AV, Cavallaro A., Cavallari N., et al. Factors influencing the rupture of abdominal aortic aneurysms. Surg Gynecol Obstet. 1991 ; 173 (3). 175-178.
21. Cronenwett JL, Sargent SK, Wall MH, et al. Variables that affect the expansion rate and outcome of small abdominal aortic aneurysms. J Vasc Surg. 1990 ; 11 (2). 260-268.
22. Bengtsson H., Nilsson P., Bergqvist D. Natural history of abdominal aortic aneurysm detected by screening. Br J Surg. 1993 ; 80 (6). 718-720.
23. Bengtsson H., Bergqvist D., Ekberg O., Ranstam J. Expansion pattern and risk of rupture of abdominal aortic aneurysms that were not operated on. Eur J Surg. 1993 ; 159 (9). 461-467.
24. Collin J., Heather B., Walton J. Growth rates of subclinical abdominal aortic aneurysms-implications for review and rescreening programmes. Eur J Vasc Surg. 1991 ; 5 (2). 141-144.
25. Vammen S., Lindholt JS, Ostergaard L., Fasting H., Henneberg EW Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg. 2001 ; 88 (8). 1066-1072.
26. Lindholt JS, Stovring J., Andersen PL, Henneberg EW, Ostergaard L. A review of macrolide treatment of atherosclerosis and abdominal aortic aneurysms. Curr Drug Targets Infect Disord. 2003 ; 3 (1). 55-63.
27. Baxter BT, Pearce WH, Waltke EA, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg. 2002 ; 36 (1). 1-12.
28. Gieffers J., Fullgraf H., Jahn J., et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation. 2001 ; 103 (3). 351-356.
29. Mpiga P., Ravaoarinoro M. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatisinfected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Int J Antimicrob Agents. 2006 ; 27 (4). 316-324.
30. Lindholt JS, Vammen S., Juul S., Henneberg EW, Fasting H. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 1999 ; 17 (6). 472-475.